By Nikki Reeves, Heather Banuelos and Gillian Russell ( October 6, 2025, 7:10 PM EDT) -- On Sept. 9, the U.S. Food and Drug Administration issued a press release announcing "sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements,"[1] while simultaneously sending a templated letter[2] to thousands of pharmaceutical companies demanding promotional compliance and over 100 cease-and-desist letters to companies for deceptive advertising related to specific products....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.